Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Total revenues, net $ 475 $ 1,173
Operating expenses:    
Cost of product sales 551 720
Research and development 6,008 9,584
Selling, general and administrative 2,708 11,684
Amortization expense 0 38
Total operating expenses 9,267 22,026
Total operating income (loss) (8,792) (20,853)
Other expense:    
Interest expense, net (949) (1,169)
Change in fair value of derivative liability (180) 0
Other expense, net (26) (20)
Total other expense, net (1,155) (1,189)
Loss before taxes (9,947) (22,042)
Income tax expense 8 9
Net loss (9,955) (22,051)
Comprehensive loss $ (9,955) $ (22,051)
Net (loss) income per share of common stock, basic (in dollars per share) $ (0.85) $ (2.35) [1]
Net (loss) income per share of common stock, diluted (in dollars per share) $ (0.85) $ (2.35) [1]
Product revenue, net    
Revenues:    
Total revenues, net $ 475 $ 1,173
[1] Amounts for prior periods presented have been retroactively adjusted to reflect the 1-for-12 reverse stock split effected on July 7, 2022. See Note 2 for details.